CENTOGENE

The Rare Disease Company CENTOGENE - transforming genetic data into medical decisions.

We are one of the worldwide leaders in the field of early genetic diagnostics for rare hereditary diseases. A data repository of genetic data from over 115 countries gives us a unique access to epidemiological, clinical and genetic information on hereditary disorders, including oncogenetic indications. We focus exclusively on providing the highest quality, patient-centred service, verified by multiple international accreditations (ISO, CAP, CLIA), regular pharmaceutical audits and our outstanding short turn-around times for analysis. We believe our medical expertise is based on cutting-edge technologies including whole exome/genome sequencing, innovative biomarkers and continued R&D. Our mutation database (CentoMD®) is the world’s largest for rare genetic diseases and is pivotal to our high-quality diagnostic reporting and comprehensive medical interpretation. CENTOGENE is a key partner for many high-profile pharmaceutical companies who are active in the orphan drug development.

01/10/2025

🌍 𝗧𝗼𝗱𝗮𝘆, 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟏𝘀𝘁, 𝗺𝗮𝗿𝗸𝘀 𝘁𝗵𝗲 𝘀𝘁𝗮𝗿𝘁 𝗼𝗳 𝗚𝗮𝘂𝗰𝗵𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵

A time when patients, families, advocates, and healthcare professionals come together to raise awareness and support for those living with Gaucher disease.

We are excited to host a special webinar: Decoding Gaucher

📅 Thursday, October 16th | 🕓 4:00 PM CEST

Join us to learn more about the Gaucher patient journey and gain insights from experts in the field.

05/09/2025

❤️ September is all about cardiovascular health awareness – and we’re celebrating with the launch of our new Cardiology Portfolio

Why does it matter?
✅ Early detection can change lives
✅ Lower risk of sudden cardiac death
✅ Better patient outcomes

What’s new?
CentoCardioVascular Panel – now powered by CentoGenome
22 new panels designed for hereditary heart disorders

💡 Discover the full portfolio in centogene.com

12/08/2025

August is SMA Awareness Month 🧠💙 Spinal Muscular Atrophy is a progressive neurodegenerative disease that causes muscle weakness and atrophy — and up to 70% of patients with neurological diseases remain genetically undiagnosed.

At CENTOGENE, we’re committed to Guiding Precision Medicine with advanced diagnostics, including our Neuromuscular Disorders Panel Upgraded Genome — now with enhanced SMN1 detection for accurate SMA diagnosis.

🔬 Early, precise diagnosis changes lives.

30/06/2025

Our red duck never misses a trip 🦆✈️

They say ducks only walk forward…just like us: always moving forward.

Come meet us (and the duck!) at Booth

26/06/2025

The countdown has begun! In just a few days, Paris will host the brightest minds in reproductive medicine at the 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗼𝗳 𝗛𝘂𝗺𝗮𝗻 𝗥𝗲𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗘𝗺𝗯𝗿𝘆𝗼𝗹𝗼𝗴𝘆 (𝗘𝗦𝗛𝗥𝗘) — and CENTOGENE will be right at the center of it all.

✨ Get a sneak peek before the doors open:
Explore what we’re bringing to ESHRE 2025 and how we’re driving the future of reproductive health with our advanced multiomic technologies.

🔗 Find our event page on our Bio

📍 Booth |🗓️ 29 June – 2 July | Paris, France

Let’s shape the future of reproductive medicine together.

20/06/2025

New CentoScreen Genome
Plan your future with precision medicine.

Our most comprehensive carrier screening test helps assess the risk of over 2,000 recessive genetic disorders — all in one test.

✔️ Powered by Whole Genome Sequencing
✔️ High accuracy
✔️ Advanced variant detection
✔️ Ideal for family planning

To learn more visit our Website.

21/05/2025

A new chapter for CENTOGENE

With a new claim, a redefined focus and the backing of Charme Capital Partners, we are ready to expand into new clinical areas and markets.

21/05/2025

Our new website marks a reflection of where we’re going.

Sharper structure, clearer message, deeper impact. Every detail is built around one purpose: We put patients at the center.

21/05/2025

At CENTOGENE we are stepping into a new chapter with renewed purpose and a bold vision for the future of Precision Medicine.

Adresse

Am Strande 7
Rostock
18055

Telefon

+4938180113416

Webseite

http://www.centogene.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von CENTOGENE erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.